Skip to main content
. 2019 Feb 13;9(2):e024655. doi: 10.1136/bmjopen-2018-024655

Figure 3.

Figure 3

Interaction between the risk of osteonecrosis of the jaw due to Sjögren’s syndrome and the use of bisphosphonates.